DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
IVAN Study Investigators, Chakravarthy U, Harding SP, Rogers CA et al.
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
Ophthalmology 2012;
119: 1399-1411
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.